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Cerebrospinal ﬂuid (CSF) is a key body ﬂuid that maintains the
homeostasis in central nervous system (CNS). As a bioﬂuid whose
content reﬂects the brain metabolic activity, the CSF is analyzed in the
context of neurological diseases and is rarely collected from healthy
subjects. For this reason, the metabolite variation associated with
general phenotypic characteristics such as gender and age have hardly
ever been studied. Here we present the hydrophilic interaction liquid
chromatography-high resolution mass spectrometry (HILIC-HRMS)
data as a result of untargeted metabolomics analysis of a cohort of
elderly cognitively healthy volunteers (n ¼ 32). 146 unambiguously
identiﬁed water soluble metabolites (using accurate mass, retention
time and MS/MS matching against spectral libraries) were measured
and their abundances across all the subjects depending on their gen-
der are provided in this article. Data tables are available at https://data.
mendeley.com/datasets/c73xtsd4s5/1. it's published on mendeley, the
DOI is DOI:10.17632/c73xtsd4s5.1. The data presented in this article are
related to the research article entitled “A global HILIC-MS approach to
measure polar human cerebrospinal ﬂuid metabolome: Exploringvier Inc. This is an open access article under the CC BY license
aca.2018.04.002
hl), julijana.ivanisevic@unil.ch (J. Ivanisevic).
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F. Mehl et al. / Data in Brief 21 (2018) 1358–1362 1359gender-associated variation in a cohort of elderly cognitively healthy
subjects” (Gallart-Ayala et al., 2018, In press).
& 2018 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations tableubject area Clinical study
ore speciﬁc subject area Metabolomics
ype of data XCMS preprocessed and signal drift corrected LC–MS data
ow data was acquired Global-untargeted metabolite proﬁling was performed using HILIC cou-
pled to high-resolution mass spectrometry (HRMS) operating in both
positive and negative (ESIþ and ESI-) mode on 6550 iFunnel Q-TOF mass
spectrometer interfaced with 1290 UHPLC system (Agilent Technologies).
Data were acquired in the full m/z range 50–1200 in both modes.ata format Tables in.txt format
xperimental factors Cerebrospinal ﬂuid samples were collected using lumbar puncture from
cognitively healthy, elderly volunteers (n ¼ 32, with no history or
symptoms of relevant psychiatric or neurologic disease, no cognitive
impairment, and without cerebral Alzheimer's disease pathology as
indicated by CSF biomarkers). Clinical characteristics of the cohort are
provided below in Experimental design section.xperimental features Cerebrospinal ﬂuid samples were extracted by the addition of ice-cold
MeOH:ACN (1:1). CSF extracts were analyzed with ESI-LS-MS system
and processed using ProFinder (Agilent Technologies) and XCMS
software. For the quality control (QC), pooled QC samples (repre-
sentative of the entire sample set) were analyzed periodically (every
7 samples) throughout the run.ata source location Metabolomics Platform, Faculty of Biology and Medicine, University of
Lausanne, Lausanne, Switzerlandata accessibility Data tables are available at https://data.mendeley.com/datasets/
c73xtsd4s5/1. it's published on mendeley, the DOI is DOI:10.17632/
c73xtsd4s5.1Value of the data
 The dataset consists of the LC-HRMS metabolomics data as a result of untargeted analyses of
cerebrospinal ﬂuid samples from a cohort of elderly cognitively healthy human subjects (n ¼ 32).
 In this paper [1], metabolites were unambiguously identiﬁed by AMRT in-house database matching
and MS/MS spectra matching against publically available spectral libraries (METLIN & mzCloud).
 The identiﬁed metabolites (n ¼ 146) are implicated in multiple metabolic pathways including
glycolysis and TCA cycle, purine and pyrimidine, amino acid and fatty acid metabolism.
 The acquired data allowed for the exploration inter-individual variability and the discovery of
gender-associated differences.1. Data
Data tables are available at https://data.mendeley.com/datasets/c73xtsd4s5/1. it's published on
mendeley, the DOI is DOI:10.17632/c73xtsd4s5.1. The dataset contains the XCMS processed and signal
F. Mehl et al. / Data in Brief 21 (2018) 1358–13621360drift corrected data. Data table is reported in.txt format and contains the information (i.e. peak areas)
about all detected metabolite features across analyzed samples and pooled quality control sample.
Metabolite features are assigned by the couple of speciﬁc RT and accurate m/z ratio information and
annotated with CAMERA for isotopes. Peaks were detected and integrated using XCMS software
(parameters are speciﬁed in Materials and Methods). Metabolites abundances were corrected for
signal drift effect by ﬁtting a locally quadratic (loess) regression model to the QC values (as described
in Materials and Methods below). A table of all identiﬁed metabolites derived from this dataset is
available as supplementary table in the research article entitled “A global HILIC-MS approach to
measure polar human cerebrospinal ﬂuid metabolome: Exploring gender-associated variation in a
cohort of elderly cognitively healthy subjects” [1]. These data were log transformed prior to univariate
statistical analysis to explore gender-associated differences.2. Experimental design, materials and methods
2.1. Study population and CSF sample collection
Cerebrospinal ﬂuid samples were collected using lumbar puncture from cognitively healthy (with
no history or symptoms of relevant psychiatric or neurologic disease, and no cognitive impairment)
volunteers (n ¼ 32) at the Department of Psychiatry and the Department of Clinical Neurosciences,
University Hospital in Lausanne, Switzerland (CHUV). The participants have been selected among
cognitively healthy, community dwelling volunteers participating on an observational cohort study
on cognitive aging and Alzheimer's disease (AD) [2]. They were recruited by announcements and
word of mouth. All participants had a comprehensive medical, neuropsychological, and psychosocial
evaluation to exclude cognitive impairment, as well as brain MRI or CT scans, and venous and lumbar
punctures. As a signiﬁcant percentage of elderly people with normal cognition may have cerebral AD
pathology, only participants with a non-AD CSF biomarker proﬁle have been included in this study
[2]. The study was approved by the cantonal ethics committee (Vaud) and informed consent was
obtained from all participants [3].
Lumbar punctures were performed between 8 and 10 a.m. after an overnight fast. For lumbar
puncture, a standardized technique with a 22-gauge “atraumatic” spinal needle and the subject in a
sitting or lying position was applied [4]. A volume of 10–12ml of CSF was collected in polypropylene
tubes. CSF samples were centrifuged, frozen in aliquots, and stored at 80 °C before further use
(Table 1).
2.2. CSF metabolite extraction
Cerebrospinal ﬂuid samples (100 μL) were extracted by the addition of 400 μL of ice-cold MeOH:
ACN (1:1, v/v) to maintain MeOH:ACN:H2O (2:2:1, v/v) ratio. The samples were then vortexed for 30 s,
incubated for 1 h at 20 °C, and ﬁnally centrifuged at 13,000 rpm at 4 °C for 15min. The resulting
supernatant was evaporated to dryness using a speedVac. The dry extracts were then reconstituted inTable 1
Clinical characteristics of the cohort studied deﬁning median and inter-quartile range.
Characteristic
Gender (male:female) 12:20
Age (median, IQR), years 65.0 (62.5,70.5)
BMI (median, IQR) 23.8 (21.8,26.1)
Smokers (non:past:active) 12:16:4
Cholesterol (median, IQR), mmol L1 6.1 (5.5,7.0)a
Glucose (median, IQR), mmol L1 5.6 (5.1,6.0)a
Creatinine (median, IQR), mmol L1 76.0 (61.0,89.3)
a Data not available for 1 subject.
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4 °C to remove the insoluble debris. The supernatants were transferred to HPLC vials and stored at
80 °C prior to LC-MS analysis.
2.3. Untargeted LC–HRMS analysis
Global-untargeted metabolite proﬁling was performed by HILIC chromatography coupled to high-
resolution mass spectrometry (HRMS) operating in both positive and negative (ESIþ and ESI-) mode
on 6550 iFunnel Q-TOF mass spectrometer interfaced with 1290 UHPLC system (Agilent Technolo-
gies). Samples were analyzed using two chromatographic separations: i) BEH Amide, 1.7 μm,
100mm  2.1mm I.D. column (Waters, Massachusetts, US) in positive ionization mode and, ii)
SeQuants ZIC-pHILIC, 5 μm, 100mm  2.1mm I.D. column (Merck, Darmstadt, Germany) with a
SeQuants ZIC-pHILIC, 5 μm, 20mm  2.1mm I.D. guard column (Merck, Darmstadt, Germany) in
negative ionization mode. The column temperature was maintained constant at 25 °C and 30 °C in
positive and negative ionization mode, respectively. The mobile phase was composed of A ¼ 20mM
ammonium formate and 0.1% formic acid in water (pH 3.8) and B ¼ 0.1% formic acid in 100% ACN for
positive mode and A¼20mM ammonium acetate and 20mM ammonium hydroxide in water (pH 9.3)
and B ¼ 100% ACN for negative mode. In positive mode, the linear elution gradient from 95% B
(0–1.5min) to 45% B (17–19min) was applied. The initial gradient conditions were restored within
one minute and a 5-min post-run re-equilibration was applied to maintain the system reproducibility.
In negative mode, the linear step-wise elution gradient from 90% B (0–1.5min) to 50% B (8–11min) to
45% B (12–15min) was applied. The initial gradient conditions were restored within one minute and a
9-min post-run equilibration was applied to maintain the system reproducibility. The ﬂow rates were
400 μLmin1 and 300 μLmin1 in positive and negative ionization mode, respectively. In both cases,
the sample injection volume was 2 ml. ESI source conditions were set as follows: dry gas temperature
290 °C and ﬂow 14 Lmin1, fragmentor voltage 380 V, sheath gas temperature 350 °C and ﬂow
12 Lmin1, nozzle voltage 0 V, and capillary voltage þ2000 V in positive mode and 2000 V in
negative. The instrument was set to acquire over the full m/z range 50–1200 in both modes, with the
MS acquisition rate of 2 spectra/s. In addition, targeted MS/MS analysis was performed using the
inclusion list of ions of interest, in narrow isolation width (1.3m/z), with a MS acquisition rate of
500ms and a MS/MS acquisition rate of 500ms at a collision energy (CE) of 20 V. For the quality
control (QC), pooled QC samples (representative of the entire sample set) were analyzed periodically
(every 7 samples) throughout the overall analytical run to assess the analytical variability and correct
for the potential signal intensity drift inherent to LC-MS technique [5].
2.4. Data processing
Raw LC-MS data were converted to mzXML ﬁles (using ProteoWizard MS Convert) and uploaded to
XCMS plus software (stand-alone server hosted within bioinformatics facility at UNIL) for data pro-
cessing including peak detection, retention time correction, proﬁle alignment, and isotope annotation
[6–8]. Data were processed as a multi-group experiment and the parameter settings were as follows:
centWave algorithm for feature detection (Δm/z ¼ 20 ppm, minimum peak width ¼ 5 s and max-
imum peak width ¼ 30 s, S/N threshold ¼ 10, mzdiff¼0.01, integration method ¼ 1, preﬁlter
peaks ¼ 3, preﬁlter intensity ¼ 10000, noise ﬁlter ¼ 5000); obiwarp settings for retention time cor-
rection (profStep ¼ 1); and parameters for chromatogram alignment, including mzwid ¼ 0.015,
minfrac ¼ 0.5 and bw ¼ 5 [9].
2.5. Signal intensity drift correction and statistical analysis
The data table containing the abundances or peak areas of all detected and identiﬁed metabolites
across all samples (CSF extracts from 32 individuals) was imported to Workﬂow4Metabolomics
[10,11] where the peak intensities were corrected for signal drift effect by ﬁtting a locally quadratic
(loess) regression model to the QC values [5,12]. The α parameter controlling the smoothing was set to
1 to avoid over ﬁtting [11].
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